london euretina

This meeting has been awarded 20 CME credits

Security Notice

Please note that Kuoni are our only destination management company. Other venders indicating that are operating for the society should be ignored. We never use western union as a payment portal

Role of oral rifampicin in central serous choroidopathy (CSC)

Session Details

Session Title: Quick Fire Free Paper 5

Session Date/Time: Sunday 14/09/2014 | 11:00-13:00

Paper Time: 12:15

Venue: Boulevard B

First Author: : M.Agarwal INDIA

Co Author(s): :    R. Venkatesh              

Abstract Details


To evaluate the role of oral rifampicin in the management of central serous choroidopathy.


Patients of non resolving chronic CSC and non resolving acute CSC with subfoveal leaks who presented to a tertiary eye care centre in North India and could not afford photodynamic therapy (PDT) were treated with oral rifampicin-300mg twice a day.


prospective analysis was done of 10 patients of non resolving CSC who were treated with oral rifampicin-300mg twice daily for 3 months after a systemic evaluation. Baseline visual acuity, fundus fluorescein angiography and optical coherence tomography were recorded and the patients were followed up


8 out of 10 pts. showed resolution of the SRF.5pts. after 1month treatment and 3 after 2 months treatment and 2 pts. were treatment failure who were having recurrent non resolving acute CSC with sub-foveal leaks out of which 1patient underwent PDT.


Rifampicin could provide a cost effective option of treatment for pts. where other modalities of treatment are not possible

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email:

Privacy policyHotel Terms and Conditions Cancellation policy